Scientists just found a molecule that could stop Parkinsons in its tracks

Researchers have designed a peptide that prevents the deadly misfolding of alpha-synuclein, the protein behind Parkinsons and some dementias. In lab and animal tests, it stabilized the protein and improved motor function. The work demonstrates the power of rational drug design in tackling brain diseases that have long lacked effective treatments.